Lumiera Health Inc announced a non-brokered private placement of up to 52,000,000 units at a price of CAD 0.025 per units for gross proceeds of CAD 1,300,000 on June 18, 2021. Each unit will consist of one common share and one common share purchase warrant, with each warrant entitling the holder to acquire one additional common share, at an exercise price of CAD 0.06 per share, for a period of four years from the date of issuance. The company intends to include an acceleration clause in the certificates representing the warrants whereby the company may accelerate the expiry of these warrants at any time prior to the expiry date in the event, the daily volume weighted average trading price of the common shares of the company on the TSX Venture Exchange exceeds CAD 0.12 for at least 10 consecutive trading days by providing written notice to the warrant holders. The warrants will, unless exercised, expire on the 30th day after the company provides the acceleration notice. The company may pay registered dealers a cash commission equal to up to 7.5% of the aggregate proceeds raised and issue broker warrants entitling such dealers to purchase such number of units equal to up to 7.5% of the aggregate of number of units issued, at the same issue price as the units. The final terms of the broker warrants will be confirmed prior to closing. The transaction is expected to close on or before July 9, 2021. The closing of the private placement is subject to certain standard conditions including, but not limited to, the receipt of all necessary approvals including the acceptance of the TSX Venture Exchange.